Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16137 articles
Assessing mortality risk in colorectal cancer survivors with congestive heart failure: a cohort study from the Taiwan Cancer Registry
CRC survivors with CHF had significantly higher mortality risk.
»
08/12/26
FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon
All metastatic tumours were FOSL2-positive.
»
08/12/26
Determination of drug sensitivity in patient derived models of breast cancer by multiparametric quantitative phase imaging
mQPI enabled robust single-cell measurements without need for extensive culture.
»
08/12/26
Comprehensive analysis of galectin-3 inhibitors GB1107 and pimasertib targeting EMT and cancer stemness pathways to suppress hepatocellular carcinoma progression
Galectin-3 inhibition by GB1107 and Pimasertib disrupts oncogenic pathways.
»
08/12/26
Development of a cell-penetrating peptide for intracellular delivery of a biologically active HPV E6 inhibitor in cervical cancer cells
CPP-pep11 induced dose- and time-dependent inhibition of proliferation.
»
08/12/26
The ABHD10-ACSL4 axis promotes pancreatic ductal adenocarcinoma growth via suppressing ferroptosis
ABHD10 depalmitoylated acyl-CoA synthetase long-chain family member 4.
»
08/12/26
Blonanserin suppresses epithelial-mesenchymal transition and stemness in glioblastoma cells by targeting PIM1
CETSA confirmed direct interaction between BNS and PIM1.
»
08/14/26
Epigenome-wide DNA methylation and genome-wide genotyping in participants entered on NSABP P-1 and P-2 breast cancer prevention trials
No CpG regions significantly associated.
»
08/14/26
Development of a cell-penetrating peptide for intracellular delivery of a biologically active HPV E6 inhibitor in cervical cancer cells
CPP-pep11 induced dose- and time-dependent inhibition of proliferation.
»
08/12/26
Clinical presentation and outcomes according to KRAS status in advanced non-small cell lung cancer
CNS more often involved in KRAS G12C-mutant cases.
»
08/15/26
< Prev
Next >